Biogen Continues To Plot New Course In Naming Two Key Executives. But Is Independence Part Of The Plan?
This article was originally published in The Pink Sheet Daily
Executive Summary
The big biotech announces Steve Holtzman, former chairman of Infinity, as head of corporate development, with Doug Williams, former CEO of ZymoGenetics stepping in as exec VP of R&D.